TB Online - Items tagged with Advocacy

With daily injections and two years of costly treatment, TB survivors look for a ray of light (post)

The 1/4/6x24 (one, four, six by 2024) campaign calls for TB patients to have access to evidence-based, long-awaited, shorter, less toxic treatment. But without mass availability of drugs, can India afford to adopt the protocol, ask experts.

Final hearing in TB drug patent case ends, verdict likely in a month (post)

New Delhi: The Indian Patent Office had held its final hearing on a challenge filed by two tuberculosis survivors to prevent the Indian arm of drugmaker Johnson & Johnson from extending its patent on bedaquiline, used against drug-resistant TB, beyond the primary patent’s expiry in July.

2023 TB HLM Affected Communities and Civil Society Coordination Hub: Deep dive calls (post)

The 2023 TB HLM Affected Communities and Civil Society Coordination Hub has been constituted to support and provide a platform for the affected communities and the civil society to engage with all processes of the upcoming 2023 UN High-Level Meeting on TB (TB HLM) scheduled for September this year in New York, USA. The Hub is hosted by the Global Fund Advocates Network (GFAN) and supported by the Stop TB Partnership.

Priority TB community, rights & gender interventions for inclusion in Global Fund applications 2023-2025 (post)

The Stop TB Partnership released new guidance, Priority TB community, rights & gender interventions for inclusion in Global Fund applications 2023-2025, outlining six priority interventions for inclusion, and containing useful annexes on engaging in Global Fund Grant Cycle 7 processes.

2023 TB HLM Affected Communities and Civil Society Coordination Hub: Deep dive calls - February calls recording & registration for March calls (post)

The 2023 TB HLM Affected Communities and Civil Society Coordination Hub has been constituted to support and provide a platform for the affected communities and the civil society to engage with all processes of the upcoming 2023 UN High-Level Meeting on TB (TB HLM) scheduled for September this year in New York, USA. The Hub is hosted by the Global Fund Advocates Network (GFAN) and supported by the Stop TB Partnership.

Call for expression of interest: Community advisory boards to support community engagement in research under the SMART4TB project (post)

The SMART4TB Consortium is calling for expressions of interest from multi-national community advisory boards or similarly organized civil society organizations within three geographic focus areas (Eastern Europe and Central Asia; Africa; and South and Southeast Asia) to support community engagement in research in a new five-year research project funded by USAID: Supporting, Mobilizing, and Accelerating Research for Tuberculosis Elimination (SMART4TB).

365 days of war: Ukrainian HIV/TB response stands strong! (post)

On February 24, 2022, at 5.00 a.m., Russia started its large-scale military offensive on the territory of Ukraine. The shortest month of a year turned out to be the longest bloodshed of a year for Ukrainians and the entire civilized world.

The Union: The latest TB training and education news (post)

The International Union Against Tuberculosis and Lung Disease (The Union) released its first quarterly training and education newsletter for 2023, sharing the latest news and updates from The Union courses.

Consultancy opportunity: TB Accountability Policy Report (post)

RESULTS UK is seeking a consultant to write an accountability policy report to support the policy advocacy efforts in the run up to the 2023 UN High-Level Meeting on TB. Further details and scope of the work are available here.

Fast-tracking progress to End TB: high-level opportunities for investment and action (post)

In the lead up to World TB Day, Dr Tereza Kasaeva, Director and Ms Hannah Monica Dias, Cross-Cutting Lead, of the WHO's Global TB Program along with Prof Madhukar Pai, Associate Director of McGill International TB Centre and Canada Research Chair in Epidemiology & Global Health, co authored a commentary in The Lancet on fast-tracking progress to End TB, emphasizing high-level opportunities for investment and action.